首页> 外文OA文献 >I.18 MET, RET, BRAF Tyrosine Kinase Inhibitors and PARP Inhibitors for Lung Cancer Therapy

【2h】

I.18 MET, RET, BRAF Tyrosine Kinase Inhibitors and PARP Inhibitors for Lung Cancer Therapy

机译：I.18 Met，RET，BRAF酪氨酸激酶抑制剂和PARP抑制剂用于肺癌治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
P.A. Bunn;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors [J] . YuH.A., SimaC.S., HuangJ., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2013,第3期

机译：EGFR酪氨酸激酶抑制剂持续治疗作为局部治疗，已发展为对EGFR酪氨酸激酶抑制剂产生耐药性的EGFR突变晚期肺癌
2. Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports [J] . Xuefei Shi, Jia Zhou, Caihua Qian, OncoTargets and therapy . 2020,第2期

机译：持续EGFR酪氨酸激酶抑制剂治疗的射频消融促进EGFR-突变生物晚期肺癌的疾病对照，获得EGFR酪氨酸激酶抑制剂的抗性：两种情况报告
3. Microwave ablation with continued EGFR tyrosine kinase inhibitor therapy prolongs disease control in non‐small‐cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors [J] . Xin Li, Han Qi, Gou Qing, Thoracic cancer. . 2018,第8期

机译：微波消融和持续的EGFR酪氨酸激酶抑制剂治疗可延长对EGFR酪氨酸激酶抑制剂具有耐药性的非小细胞肺癌的疾病控制
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Enhancing the Therapeutic Effects of Low Doses of Ionizing Radiation in Non-Small Cell Lung Cancers Using a Combination of PARP Inhibitors and DNA Demethylating Agents. [D] . Biondi, Christopher Anthony. 2016

机译：使用PARP抑制剂和DNA去甲基化剂的组合增强非小细胞肺癌低剂量电离辐射的治疗效果。
6. Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors [O] . Helena A. Yu, Camelia S. Sima, James Huang, -1

机译：局部治疗与持续EGFR酪氨酸激酶抑制剂治疗作为EGFR突变先进肺癌治疗策略已经发展到获得的EGFR酪氨酸激酶抑制剂的抗性
7. Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors [O] . Yu Helena A., Sima Camelia S., Huang James, 2013

机译：EGFR酪氨酸激酶抑制剂持续治疗作为局部治疗的EGFR突变晚期肺癌已获得对EGFR酪氨酸激酶抑制剂的耐药性。

I.18 MET, RET, BRAF Tyrosine Kinase Inhibitors and PARP Inhibitors for Lung Cancer Therapy

著录项

引文网络

相似文献

相关主题

期刊订阅